Clinical Trials Directory

Trials / Terminated

TerminatedNCT01075412

FLT PET Imaging for Cervical Cancer

'F-18 Fluorothymidine ([18F]FLT) PET Imaging for Early Evaluation of Response to Chemoradiation Therapy in Patients With Cervical Cancer

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
6 (actual)
Sponsor
University of Iowa · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Our primary hypothesis is that \[18F\]FLT PET can identify active bone marrow in addition to metabolically active tumor. This trial will use FLT-PET imaging to define areas of active bone marrow in the pelvis. The radiation plan is then designed to spare that area, in hopes of keeping the bone marrow active during therapy. Bone marrow and tumor activity will be monitored using a sequence of FLT PET scans during the course of chemotherapy and radiation therapy.

Detailed description

Subjects will undergo a total of up to 5 FLT PET scans. Subjects are randomized between two groups to reduce radiation exposure from the FLT PET scans. If bone marrow activity is not identified in one scan, further scans are cancelled until the 1-month follow up scan. This is not a randomization to compare therapeutic efficacy between two study arms. Data will be pooled for analysis as pre-specified in the study's statistical plan. Group 1 has FLT PET scans pretreatment, after 5 radiation treatments, after 10 radiation treatments, after 15 radiation treatments, and then 1 month after completing radiation therapy. Group 2 has FLT PET scans pretreatment, after 5 radiation treatments, after 10 radiation treatments, after 20 radiation treatments, and then 1 month after completing radiation therapy.

Conditions

Interventions

TypeNameDescription
DRUG[F18]FluorothymidineFLT PET scan 5 mCi (+/- 10%)

Timeline

Start date
2009-09-01
Primary completion
2016-03-03
Completion
2016-04-11
First posted
2010-02-25
Last updated
2017-12-02
Results posted
2017-12-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01075412. Inclusion in this directory is not an endorsement.